Description
CCB02 is a selective CPAP-tubulin interaction inhibitor (IC50: 689nM) with anti-tumor activity. CCB02 shows no inhibition on the cell cycle- and centrosome-related kinases, or the phosphorylation status of Aurora-A, CDK2, Plk1, Plk2, and CHK1